Tetra Trust Launches Canada’s First Regulated CAD Stablecoin CADD

Context Canada processes roughly $424 billion in daily payments on legacy batch systems dating to the 1980s. The global stablecoin market, now valued at $320 billion, is dominated by U.S.‑dollar tokens, leaving Canadian institutions without a domestic on‑chain alternative. Stablecoin transaction volume topped $27 trillion in 2025, surpassing Visa’s annual payment flow.

Key Facts - Tetra Trust, a regulated digital‑asset custodian, received approval from the Alberta Treasury Board and Finance to issue CADD, a CAD‑pegged token whose reserves sit in a Canadian‑law trust for redemption. - The token launched on Base, Ethereum and Tempo blockchains; Solana support is slated for later 2026. - A $10 million funding round closed in September 2025, led by Shopify, Wealthsimple, Purpose Unlimited, Shakepay, ATB Financial, National Bank of Canada and Urbana Corporation, which now holds a majority stake. - In December, Tetra completed a testnet transfer of CADD between Wealthsimple and National Bank, marking the first inter‑institutional movement of a Canadian stablecoin. - CADD is positioned for institutional use cases: 24/7 cross‑border settlement, real‑time corporate treasury transfers, programmable marketplace payouts and direct fintech‑to‑fintech settlement, aiming to replace batch‑based correspondent banking.

What It Means CADD gives Canadian corporates a regulated on‑chain CAD bridge, potentially reducing settlement times from days to seconds and cutting reliance on U.S.‑dollar stablecoins. If adoption mirrors global trends, the token could capture a share of the $424 billion daily payment flow, driving demand for Canadian‑denominated digital assets. Competitors such as Stablecorp’s QCAD and Loon’s CADC remain in early stages, giving Tetra a first‑mover advantage.

Watch Next Monitor CADD’s on‑chain volume and any integration with major Canadian banks, as well as regulatory updates from the Ontario Securities Commission that could affect competing stablecoins.